Skip to search formSkip to main contentSkip to account menu

response to clopidogrel

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
Abstract Introduction: The anti-platelet agent clopidogrel is a commonly prescribed medication in patients in patients who are… 
2014
2014
O-021 Induced Hyper-Response to Clopidogrel after Elective Endovascular Intracranial Aneurysm Treatment
Introduction A variable response to clopidogrel among patients undergoing neurointerventional procedures has been observed. To… 
2012
2012
Abstract 17455: Pharmacodynamic Response to Clopidogrel in Men versus Women: Insights from the PRINCIPLE-TIMI 44 Trial
Background: Concerns have been raised regarding the relative efficacy and safety of antiplatelet drugs in women. It remains… 
2011
2011
Predicting Clinical Response to Clopidogrel — Does Genetic Testing Help?
Because clopidogrel is a prodrug that's activated through cytochrome P450-related pathways, genetic variants of the CYP2C19… 
2010
2010
Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availability
The anti-platelet agent clopidogrel bisulfate (sold under the trade name Plavix in the United States) is a widely prescribed… 
2009
2009
Many Elective Angiographies Are Deemed Unnecessary, Data Show
2009
2009
A Genotype Associated with Diminished Response to Clopidogrel
Clopidogrel improves outcomes in most patients with acute coronary syndromes, but poor responsiveness to clopidogrel is common… 
2008
2008
Abstract 4020: A Possible Mechanism of Poorer and more Variable Response to Clopidogrel than Prasugrel
2006
2006
Abstract 3284: Limited Accuracy of a New Point-Of-Service Assay for Assessing Inhibition of Platelet Aggregation in Response to Clopidogrel and Aspirin
Suboptimal response (“resistance”) to the platelet inhibitory effects of clopidogrel has been implicated in increased risk of… 
2005
2005
Inter-individual variability in response to clopidogrel in patients with coronary artery disease.
BACKGROUND Clopidogrel, especially when combined with aspirin, reduces the rate of ischaemic events in patients with coronary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)